(Mark
One)
|
|
[X]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended March 31, 2012
|
|
OR
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from ______________ to ______________
|
Commission file number 1-12626
|
EASTMAN CHEMICAL COMPANY
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
62-1539359
|
|
(State or other jurisdiction of
|
(I.R.S. employer
|
|
incorporation or organization)
|
identification no.)
|
|
200 South Wilcox Drive
|
||
Kingsport, Tennessee
|
37662
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Registrant's telephone number, including area code: (423) 229-2000
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES [X] NO [ ]
|
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
YES [X] NO [ ]
|
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer [X] Accelerated filer [ ]
Non-accelerated filer [ ] Smaller reporting company [ ]
(Do not check if a smaller reporting company)
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YES [ ] NO [X]
|
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.
|
||
Class
|
Number of Shares Outstanding at March 31, 2012
|
|
Common Stock, par value $0.01 per share
|
137,958,478
|
|
ITEM
|
PAGE
|
1.
|
Financial Statements
|
|
3
|
||
4
|
||
5
|
||
6
|
||
2.
|
25
|
|
3.
|
44
|
|
4.
|
44
|
1.
|
45
|
|
1A.
|
46
|
|
6.
|
46
|
47
|
First Three Months
|
||||||||
(Dollars in millions, except per share amounts)
|
2012
|
2011
|
||||||
Sales
|
$ | 1,821 | $ | 1,758 | ||||
Cost of sales
|
1,390 | 1,300 | ||||||
Gross profit
|
431 | 458 | ||||||
Selling, general and administrative expenses
|
126 | 108 | ||||||
Research and development expenses
|
41 | 36 | ||||||
Operating earnings
|
264 | 314 | ||||||
Net interest expense
|
19 | 19 | ||||||
Other charges (income), net
|
1 | (6 | ) | |||||
Earnings from continuing operations before income taxes
|
244 | 301 | ||||||
Provision for income taxes from continuing operations
|
85 | 100 | ||||||
Earnings from continuing operations
|
159 | 201 | ||||||
Earnings from discontinued operations, net of tax
|
-- | 9 | ||||||
Gain (loss) from disposal of discontinued operations, net of tax
|
(1 | ) | 30 | |||||
Net earnings
|
$ | 158 | $ | 240 | ||||
Basic earnings per share
|
||||||||
Earnings from continuing operations
|
$ | 1.15 | $ | 1.42 | ||||
Earnings from discontinued operations
|
-- | 0.28 | ||||||
Basic earnings per share
|
$ | 1.15 | $ | 1.70 | ||||
Diluted earnings per share
|
||||||||
Earnings from continuing operations
|
$ | 1.13 | $ | 1.39 | ||||
Earnings (loss) from discontinued operations
|
(0.01 | ) | 0.27 | |||||
Diluted earnings per share
|
$ | 1.12 | $ | 1.66 | ||||
Comprehensive Income
|
||||||||
Net earnings
|
$ | 158 | $ | 240 | ||||
Other comprehensive income (loss), net of tax
|
||||||||
Change in cumulative translation adjustment
|
15 | 25 | ||||||
Defined benefit pension and other postretirement benefit plans:
|
||||||||
Amortization of unrecognized prior service credit included in net periodic costs
|
(5 | ) | (8 | ) | ||||
Derivatives and hedging:
|
||||||||
Unrealized gain (loss) during period
|
10 | (13 | ) | |||||
Reclassification adjustment for gains included in net income
|
(5 | ) | (1 | ) | ||||
Total other comprehensive income (loss), net of tax
|
15 | 3 | ||||||
Comprehensive income
|
$ | 173 | $ | 243 | ||||
Retained Earnings
|
||||||||
Retained earnings at beginning of period
|
$ | 2,760 | $ | 2,253 | ||||
Net earnings
|
158 | 240 | ||||||
Cash dividends declared
|
(36 | ) | (34 | ) | ||||
Retained earnings at end of period
|
$ | 2,882 | $ | 2,459 |
March 31,
|
December 31,
|
|||||||
(Dollars in millions, except per share amounts)
|
2012
|
2011
|
||||||
(Unaudited)
|
||||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
$ | 569 | $ | 577 | ||||
Short-term time deposits
|
80 | 200 | ||||||
Trade receivables, net
|
740 | 632 | ||||||
Miscellaneous receivables
|
68 | 72 | ||||||
Inventories
|
768 | 779 | ||||||
Other current assets
|
39 | 42 | ||||||
Total current assets
|
2,264 | 2,302 | ||||||
Properties
|
||||||||
Properties and equipment at cost
|
8,479 | 8,383 | ||||||
Less: Accumulated depreciation
|
5,343 | 5,276 | ||||||
Net properties
|
3,136 | 3,107 | ||||||
Goodwill
|
408 | 406 | ||||||
Other noncurrent assets
|
383 | 369 | ||||||
Total assets
|
$ | 6,191 | $ | 6,184 | ||||
Liabilities and Stockholders' Equity
|
||||||||
Current liabilities
|
||||||||
Payables and other current liabilities
|
$ | 846 | $ | 961 | ||||
Borrowings due within one year
|
151 | 153 | ||||||
Total current liabilities
|
997 | 1,114 | ||||||
Long-term borrowings
|
1,444 | 1,445 | ||||||
Deferred income tax liabilities
|
223 | 210 | ||||||
Post-employment obligations
|
1,395 | 1,411 | ||||||
Other long-term liabilities
|
107 | 134 | ||||||
Total liabilities
|
4,166 | 4,314 | ||||||
Stockholders' equity
|
||||||||
Common stock ($0.01 par value – 350,000,000 shares authorized; shares issued – 197,409,655 and 196,455,131 for 2012 and 2011, respectively)
|
2 | 2 | ||||||
Additional paid-in capital
|
918 | 900 | ||||||
Retained earnings
|
2,882 | 2,760 | ||||||
Accumulated other comprehensive income
|
153 | 138 | ||||||
3,955 | 3,800 | |||||||
Less: Treasury stock at cost (59,539,633 shares for 2012 and 2011)
|
1,930 | 1,930 | ||||||
Total stockholders' equity
|
2,025 | 1,870 | ||||||
Total liabilities and stockholders' equity
|
$ | 6,191 | $ | 6,184 | ||||
First Three Months
|
||||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
Cash flows from operating activities
|
||||||||
Net earnings
|
$ | 158 | $ | 240 | ||||
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
|
||||||||
Depreciation and amortization
|
69 | 68 | ||||||
Gain on sale of assets
|
-- | (52 | ) | |||||
Provision (benefit) for deferred income taxes
|
13 | (40 | ) | |||||
Pension and other postretirement contributions (in excess of) less than expenses
|
(27 | ) | (114 | ) | ||||
Variable compensation (in excess of) less than expenses
|
(71 | ) | (82 | ) | ||||
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:
|
||||||||
(Increase) decrease in trade receivables
|
(103 | ) | (229 | ) | ||||
(Increase) decrease in inventories
|
14 | (49 | ) | |||||
Increase (decrease) in trade payables
|
(20 | ) | 8 | |||||
Other items, net
|
(14 | ) | 104 | |||||
Net cash provided by (used in) operating activities
|
19 | (146 | ) | |||||
Cash flows from investing activities
|
||||||||
Additions to properties and equipment
|
(90 | ) | (97 | ) | ||||
Proceeds from sale of short-term time deposits
|
120 | -- | ||||||
Proceeds from sale of assets and investments
|
6 | 617 | ||||||
Acquisitions and investments in joint ventures
|
(10 | ) | -- | |||||
Additions to short-term time deposits
|
-- | (200 | ) | |||||
Additions to capitalized software
|
(1 | ) | (2 | ) | ||||
Other items, net
|
(35 | ) | (11 | ) | ||||
Net cash provided by (used in) investing activities
|
(10 | ) | 307 | |||||
Cash flows from financing activities
|
||||||||
Net increase in commercial paper, credit facility, and other borrowings
|
(1 | ) | 1 | |||||
Dividends paid to stockholders
|
(36 | ) | (34 | ) | ||||
Treasury stock purchases
|
-- | (74 | ) | |||||
Proceeds from stock option exercises and other items, net
|
20 | 70 | ||||||
Net cash used in financing activities
|
(17 | ) | (37 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents
|
-- | -- | ||||||
Net change in cash and cash equivalents
|
(8 | ) | 124 | |||||
Cash and cash equivalents at beginning of period
|
577 | 516 | ||||||
Cash and cash equivalents at end of period
|
$ | 569 | $ | 640 | ||||
Page
|
|
Note 1. Basis of Presentation
|
7
|
7
|
|
12
|
|
Note 4. Discontinued Operations
|
12
|
Note 5. Inventories
|
13
|
13
|
|
Note 7. Provision for Income Taxes
|
13
|
Note 8. Borrowings
|
14
|
Note 9. Derivatives
|
15
|
Note 10. Retirement Plans
|
17
|
Note 11. Commitments
|
18
|
Note 12. Environmental Matters
|
19
|
Note 13. Legal Matters
|
20
|
Note 14. Stockholders' Equity
|
20
|
Note 15. Earnings and Dividends Per Share
|
21
|
21
|
|
Note 17. Share-Based Compensation Awards
|
22
|
Note 18. Supplemental Cash Flow Information
|
22
|
Note 19. Segment Information
|
22
|
Note 20. Recently Issued Accounting Standards
|
24
|
1.
|
BASIS OF PRESENTATION
|
2.
|
ACCOUNTING METHODOLOGY CHANGE FOR PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
|
Unaudited Condensed Consolidated Statement of Earnings
|
||||||||||||
Three Months Ended March 31, 2012
|
||||||||||||
(Dollars in millions, except per share amounts, unaudited)
|
Previous Accounting Method
|
Effect of Accounting Change
|
As Reported
|
|||||||||
Cost of sales
|
$ | 1,405 | $ | (15 | ) | $ | 1,390 | |||||
Gross profit
|
416 | 15 | 431 | |||||||||
Selling, general and administrative expenses
|
130 | (4 | ) | 126 | ||||||||
Operating earnings
|
245 | 19 | 264 | |||||||||
Earnings from continuing operations before income taxes
|
225 | 19 | 244 | |||||||||
Provision for income taxes from continuing operations
|
78 | 7 | 85 | |||||||||
Earnings from continuing operations
|
147 | 12 | 159 | |||||||||
Net earnings
|
146 | 12 | 158 | |||||||||
Basic earnings per share
|
||||||||||||
Earnings from continuing operations
|
$ | 1.06 | $ | 0.09 | $ | 1.15 | ||||||
Diluted earnings per share
|
||||||||||||
Earnings from continuing operations
|
$ | 1.05 | $ | 0.08 | $ | 1.13 | ||||||
Diluted earnings per share
|
1.04 | 0.08 | 1.12 | |||||||||
Comprehensive Income
|
||||||||||||
Net earnings
|
$ | 146 | $ | 12 | $ | 158 | ||||||
Amortization of prior service credit included in net periodic costs (1)
|
8 | (13 | ) | (5 | ) | |||||||
Total other comprehensive income (loss), net of tax
|
28 | (13 | ) | 15 | ||||||||
Comprehensive income
|
174 | (1 | ) | 173 | ||||||||
Retained Earnings
|
||||||||||||
Retained earnings at beginning of period
|
$ | 3,436 | $ | (676 | ) | $ | 2,760 | |||||
Net earnings
|
146 | 12 | 158 | |||||||||
Retained earnings at end of period
|
3,546 | (664 | ) | 2,882 | ||||||||
(1)
|
Updated to reflect first quarter 2012 presentation of other comprehensive income.
|
Unaudited Condensed Consolidated Statement of Earnings
|
||||||||||||
Three Months Ended March 31, 2011
|
||||||||||||
(Dollars in millions, except per share amounts, unaudited)
|
As Previously Reported (Before Accounting Change)
|
Effect of Accounting Change
|
As Adjusted (After Accounting Change)
|
|||||||||
Cost of sales
|
$ | 1,325 | $ | (25 | ) | $ | 1,300 | |||||
Gross profit
|
433 | 25 | 458 | |||||||||
Selling, general and administrative expenses
|
113 | (5 | ) | 108 | ||||||||
Operating earnings
|
284 | 30 | 314 | |||||||||
Earnings from continuing operations before income taxes
|
271 | 30 | 301 | |||||||||
Provision for income taxes from continuing operations
|
89 | 11 | 100 | |||||||||
Earnings from continuing operations
|
182 | 19 | 201 | |||||||||
Earnings from discontinued operations, net of tax
|
8 | 1 | 9 | |||||||||
Net earnings
|
220 | 20 | 240 | |||||||||
Basic earnings per share
|
||||||||||||
Earnings from continuing operations
|
$ | 1.29 | $ | 0.13 | $ | 1.42 | ||||||
Earnings from discontinued operations
|
0.26 | 0.02 | 0.28 | |||||||||
Basic earnings per share
|
$ | 1.55 | $ | 0.15 | $ | 1.70 | ||||||
Diluted earnings per share
|
||||||||||||
Earnings from continuing operations
|
$ | 1.26 | $ | 0.13 | $ | 1.39 | ||||||
Earnings from discontinued operations
|
0.26 | 0.01 | 0.27 | |||||||||
Diluted earnings per share
|
$ | 1.52 | $ | 0.14 | $ | 1.66 | ||||||
Comprehensive Income
|
||||||||||||
Net earnings
|
$ | 220 | $ | 20 | $ | 240 | ||||||
Amortization of prior service credit included in net periodic costs (1)
|
4 | (12 | ) | (8 | ) | |||||||
Total other comprehensive income (loss), net of tax
|
15 | (12 | ) | 3 | ||||||||
Comprehensive income
|
235 | 8 | 243 | |||||||||
Retained Earnings
|
||||||||||||
Retained earnings at beginning of period
|
$ | 2,880 | $ | (627 | ) | $ | 2,253 | |||||
Net earnings
|
220 | 20 | 240 | |||||||||
Retained earnings at end of period
|
3,066 | (607 | ) | 2,459 | ||||||||
(1)
|
Updated to reflect first quarter 2012 presentation of other comprehensive income.
|
Consolidated Statements of Financial Position
|
||||||||||||
March 31, 2012
|
||||||||||||
(Dollars in millions, unaudited)
|
Previous Accounting Method
|
Effect of Accounting Change
|
As Reported
|
|||||||||
Other noncurrent assets
|
$ | 382 | $ | 1 | $ | 383 | ||||||
Post-employment obligations
|
1,393 | 2 | 1,395 | |||||||||
Retained earnings
|
3,546 | (664 | ) | 2,882 | ||||||||
Accumulated other comprehensive income (loss)
|
(510 | ) | 663 | 153 |
December 31, 2011
|
||||||||||||
(Dollars in millions)
|
As Previously Reported (Before Accounting Change)
|
Effect of Accounting Change
|
As Adjusted (After Accounting Change)
|
|||||||||
Retained earnings
|
$ | 3,436 | $ | (676 | ) | $ | 2,760 | |||||
Accumulated other comprehensive income (loss)
|
(538 | ) | 676 | 138 |
Unaudited Consolidated Statements of Cash Flows
|
||||||||||||
Three Months Ended March 31, 2012
|
||||||||||||
(Dollars in millions)
|
Previous Accounting Method
|
Effect of Accounting Change
|
As Reported
|
|||||||||
Net earnings
|
$ | 146 | $ | 12 | $ | 158 | ||||||
Provision (benefit) for deferred income taxes
|
6 | 7 | 13 | |||||||||
Pension and other postretirement contributions (in excess of) less than expenses
|
(16 | ) | (11 | ) | (27 | ) | ||||||
Other items, net
|
(6 | ) | (8 | ) | (14 | ) |
Three Months Ended March 31, 2011
|
||||||||||||
(Dollars in millions)
|
As Previously Reported (Before Accounting Change)
|
Effect of Accounting Change
|
As Adjusted (After Accounting Change)
|
|||||||||
Net earnings
|
$ | 220 | $ | 20 | $ | 240 | ||||||
Provision (benefit) for deferred income taxes
|
(52 | ) | 12 | (40 | ) | |||||||
Pension and other postretirement contributions (in excess of) less than expenses (1)
|
(88 | ) | (26 | ) | (114 | ) | ||||||
Other items, net (1)
|
110 | (6 | ) | 104 |
(1)
|
Updated to reflect first quarter 2012 presentation of cash flows from operating activities.
|
3.
|
ACQUISITIONS AND INVESTMENTS IN JOINT VENTURES
|
Dollars in millions
|
||||
Current assets
|
$ | 33 | ||
Properties and equipment
|
129 | |||
Intangible assets
|
11 | |||
Other noncurrent assets
|
20 | |||
Goodwill
|
33 | |||
Current liabilities
|
(23 | ) | ||
Long-term liabilities
|
(70 | ) | ||
Total purchase price
|
$ | 133 |
4.
|
DISCONTINUED OPERATIONS
|
For three months ended March 31, | ||||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
Sales
|
$ | -- | $ | 105 | ||||
Earnings before income taxes
|
-- | 18 | ||||||
Earnings from discontinued operations, net of tax
|
-- | 9 | ||||||
Gain (loss) from disposal of discontinued operations, net of tax
|
(1 | ) | 30 |
5.
|
INVENTORIES
|
March 31,
|
December 31,
|
|||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
At FIFO or average cost (approximates current cost)
|
||||||||
Finished goods
|
$ | 745 | $ | 777 | ||||
Work in process
|
229 | 239 | ||||||
Raw materials and supplies
|
374 | 353 | ||||||
Total inventories
|
1,348 | 1,369 | ||||||
LIFO Reserve
|
(580 | ) | (590 | ) | ||||
Total inventories
|
$ | 768 | $ | 779 |
6.
|
PAYABLES AND OTHER CURRENT LIABILITIES
|
March 31,
|
December 31,
|
|||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
Trade creditors
|
$ | 512 | $ | 529 | ||||
Accrued payrolls, vacation, and variable-incentive compensation
|
51 | 146 | ||||||
Accrued taxes
|
67 | 40 | ||||||
Post-employment obligations
|
57 | 58 | ||||||
Interest payable
|
26 | 26 | ||||||
Other
|
133 | 162 | ||||||
Total payables and other current liabilities
|
$ | 846 | $ | 961 |
7.
|
PROVISION FOR INCOME TAXES
|
First Quarter
|
||||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
Provision for income taxes
|
$ | 85 | $ | 100 | ||||
Effective tax rate
|
35 | % | 33 | % |
8.
|
BORROWINGS
|
March 31,
|
December 31,
|
|||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
Borrowings consisted of:
|
||||||||
7% notes due 2012
|
$ | 147 | $ | 147 | ||||
3% debentures due 2015
|
250 | 250 | ||||||
6.30% notes due 2018
|
175 | 176 | ||||||
5.5% notes due 2019
|
250 | 250 | ||||||
4.5% debentures due 2021
|
250 | 250 | ||||||
7 1/4% debentures due 2024
|
243 | 243 | ||||||
7 5/8% debentures due 2024
|
54 | 54 | ||||||
7.60% debentures due 2027
|
222 | 222 | ||||||
Credit facility borrowings
|
-- | -- | ||||||
Other
|
4 | 6 | ||||||
Total borrowings
|
1,595 | 1,598 | ||||||
Borrowings due within one year
|
(151 | ) | (153 | ) | ||||
Long-term borrowings
|
$ | 1,444 | $ | 1,445 |
March 31, 2012
|
December 31, 2011
|
|||||||||||||||
(Dollars in millions)
|
Recorded Amount
|
Fair Value
|
Recorded Amount
|
Fair Value
|
||||||||||||
Long-term borrowings
|
$ | 1,444 | $ | 1,617 | $ | 1,445 | $ | 1,656 |
9.
|
DERIVATIVES
|
(Dollars in millions)
|
Fair Value Measurements
Significant Other Observable Inputs
(Level 2)
|
||||||||
Derivative Assets
|
Statement of Financial Position Location
|
March 31, 2012
|
December 31, 2011
|
||||||
Cash Flow Hedges
|
|||||||||
Commodity contracts
|
Other current assets
|
$ | -- | $ | 1 | ||||
Commodity contracts
|
Other noncurrent assets
|
-- | 1 | ||||||
Foreign exchange contracts
|
Other current assets
|
14 | 20 | ||||||
Foreign exchange contracts
|
Other noncurrent assets
|
11 | 12 | ||||||
Forward starting interest rate swap contracts
|
Other current assets
|
10 | -- | ||||||
$ | 35 | $ | 34 |
(Dollars in millions)
|
Fair Value Measurements
Significant Other Observable Inputs
(Level 2)
|
||||||||
Derivative Liabilities
|
Statement of Financial Position Location
|
March 31, 2012
|
December 31, 2011
|
||||||
Cash Flow Hedges
|
|||||||||
Commodity contracts
|
Payables and other current liabilities
|
$ | 2 | $ | 8 | ||||
Commodity contracts
|
Other long-term liabilities
|
1 | -- | ||||||
Foreign exchange contracts
|
Payables and other current liabilities
|
4 | 7 | ||||||
Foreign exchange contracts
|
Other long-term liabilities
|
1 | 7 | ||||||
Forward starting interest rate swap contracts
|
Payables and other current liabilities
|
-- | 1 | ||||||
$ | 8 | $ | 23 |
(Dollars in millions)
|
Amount after tax of gain/ (loss) recognized in Other Comprehensive Income on derivatives (effective portion)
|
Location of gain/(loss) reclassified from Accumulated Other Comprehensive Income into |
Pre-tax amount of gain/(loss) reclassified from Accumulated Other Comprehensive Income into income (effective portion)
|
||||||||||||||
Derivatives' Cash Flow Hedging Relationships
|
March 31, 2012
|
March 31, 2011
|
income (effective portion) |
March 31, 2012
|
March 31, 2011
|
||||||||||||
Commodity contracts
|
$ | (7 | ) | $ | 2 |
Cost of sales
|
$ | -- | $ | -- | |||||||
Foreign exchange contracts
|
(1 | ) | (16 | ) |
Sales
|
8 | 1 | ||||||||||
Forward starting interest rate swap contracts
|
13 | -- |
Interest Expense
|
-- | -- | ||||||||||||
$ | 5 | $ | (14 | ) | $ | 8 | $ | 1 |
10.
|
RETIREMENT PLANS
|
First Quarter
|
||||||||||||||||
Pension Plans
|
Postretirement Welfare Plans
|
|||||||||||||||
(Dollars in millions)
|
2012
|
2011
|
2012
|
2011
|
||||||||||||
Service cost
|
$ | 12 | $ | 12 | $ | 2 | $ | 2 | ||||||||
Interest cost
|
21 | 21 | 11 | 11 | ||||||||||||
Expected return on assets
|
(25 | ) | (25 | ) | -- | (1 | ) | |||||||||
Curtailment gain (1)
|
-- | -- | -- | (7 | ) | |||||||||||
Amortization of:
|
||||||||||||||||
Prior service credit
|
(1 | ) | (3 | ) | (5 | ) | (5 | ) | ||||||||
Mark-to-market gain (2)
|
-- | -- | -- | (15 | ) | |||||||||||
Net periodic benefit cost
|
$ | 7 | $ | 5 | $ | 8 | $ | (15 | ) |
(1)
|
Gain for the Performance Polymers segment that was sold January 31, 2011 and is included in discontinued operations. For more information, see Note 4, "Discontinued Operations."
|
(2)
|
Mark-to-market gain due to the interim remeasurement of the OPEB plan obligation, triggered by the exit of employees associated with the sale of the PET business.
|
11.
|
COMMITMENTS
|
12.
|
ENVIRONMENTAL MATTERS
|
13.
|
LEGAL MATTERS
|
14.
|
STOCKHOLDERS' EQUITY
|
(Dollars in millions)
|
Common Stock at Par Value
$
|
Paid-in Capital
$
|
Retained Earnings
$
|
Accumulated Other Comprehensive Income
$
|
Treasury Stock at Cost
$
|
Total Stockholders' Equity
$
|
||||||||||||||||||
Balance at December 31, 2011 (1) (2)
|
2 | 900 | 2,760 | 138 | (1,930 | ) | 1,870 | |||||||||||||||||
Net Earnings
|
-- | -- | 158 | -- | -- | 158 | ||||||||||||||||||
Cash Dividends Declared (3)
|
-- | -- | (36 | ) | -- | -- | (36 | ) | ||||||||||||||||
Other Comprehensive Income
|
-- | -- | -- | 15 | -- | 15 | ||||||||||||||||||
Share-Based Compensation Expense (4)
|
-- | 7 | -- | -- | -- | 7 | ||||||||||||||||||
Stock Option Exercises
|
-- | 7 | -- | -- | -- | 7 | ||||||||||||||||||
Other (5)
|
-- | 4 | -- | -- | -- | 4 | ||||||||||||||||||
Stock Repurchases
|
-- | -- | -- | -- | -- | -- | ||||||||||||||||||
Balance at March 31, 2012
|
2 | 918 | 2,882 | 153 | (1,930 | ) | 2,025 |
(1)
|
Common Stock at Par Value and Retained Earnings have been adjusted for the two-for-one stock split on October 3, 2011. For additional information, see Note 1, "Basis of Presentation" and Note 15, "Earnings and Dividends Per Share".
|
(2)
|
Retained Earnings and Accumulated Other Comprehensive Income have been adjusted for the change in accounting methodology for pension and OPEB plans. For additional information, see Note 2, "Accounting Methodology Change for Pension and Other Postretirement Benefit Plans".
|
(3)
|
Includes cash dividends declared, but unpaid.
|
(4)
|
Includes the fair value of equity share-based awards recognized for share-based compensation.
|
(5)
|
Includes tax benefits relating to the difference between the amounts deductible for federal income taxes over the amounts charged to income for book value purposes credited to paid-in capital and other items.
|
(Dollars in millions)
|
Cumulative Translation Adjustment
$
|
Unrecognized Prior Service Credits for Benefit Plans (1)
$
|
Unrealized Gains (Losses) on Derivative Instruments
$
|
Unrealized Losses on Investments
$
|
Accumulated Other Comprehensive Income (Loss)
$
|
|||||||||||||||
Balance at December 31, 2010 (1)
|
79 | 99 | 17 | (1 | ) | 194 | ||||||||||||||
Period change
|
(15 | ) | (21 | ) | (20 | ) | -- | (56 | ) | |||||||||||
Balance at December 31, 2011 (1)
|
64 | 78 | (3 | ) | (1 | ) | 138 | |||||||||||||
Period change
|
15 | (5 | ) | 5 | -- | 15 | ||||||||||||||
Balance at March 31, 2012
|
79 | 73 | 2 | (1 | ) | 153 |
(1)
|
Unrecognized Prior Service Credits for Benefit Plans have been adjusted for the change in accounting methodology for pension and OPEB plans. For additional information, see Note 2, "Accounting Methodology Change for Pension and Other Postretirement Benefit Plans".
|
15.
|
EARNINGS AND DIVIDENDS PER SHARE
|
First Quarter
|
||||||||
2012
|
2011
|
|||||||
Shares used for earnings per share calculation (in millions):
|
||||||||
Basic
|
137.3 | 141.4 | ||||||
Diluted
|
140.7 | 144.6 |
16.
|
ASSET IMPAIRMENTS AND RESTRUCTURING CHARGES (GAINS), NET
|
(Dollars in millions)
|
Balance at
January 1, 2011
|
Provision/ Adjustments
|
Non-cash Reductions
|
Cash Reductions
|
Balance at
December 31, 2011
|
|||||||||||||||
Non-cash charges
|
$ | -- | $ | (15 | ) | $ | 15 | $ | -- | $ | -- | |||||||||
Severance costs
|
15 | 7 | -- | (20 | ) | 2 | ||||||||||||||
Total
|
$ | 15 | $ | (8 | ) | $ | 15 | $ | (20 | ) | $ | 2 | ||||||||
Balance at January 1, 2012
|
Provision/ Adjustments
|
Non-cash Reductions
|
Cash Reductions
|
Balance at March 31, 2012
|
||||||||||||||||
Non-cash charges
|
$ | -- | $ | -- | $ | -- | $ | -- | $ | -- | ||||||||||
Severance costs
|
2 | -- | -- | (1 | ) | 1 | ||||||||||||||
Total
|
$ | 2 | $ | -- | $ | -- | $ | (1 | ) | $ | 1 |
17.
|
SHARE-BASED COMPENSATION AWARDS
|
18.
|
SUPPLEMENTAL CASH FLOW INFORMATION
|
(Dollars in millions)
|
First Three Months
|
|||||||
2012
|
2011
|
|||||||
Current assets
|
$ | 2 | $ | 13 | ||||
Other assets
|
12 | 24 | ||||||
Current liabilities
|
(3 | ) | 90 | |||||
Long-term liabilities and equity
|
(25 | ) | (23 | ) | ||||
Total
|
$ | (14 | ) | $ | 104 |
19.
|
SEGMENT INFORMATION
|
First Three Months
|
||||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
Sales
|
||||||||
CASPI
|
$ | 470 | $ | 467 | ||||
Fibers
|
323 | 290 | ||||||
PCI
|
736 | 694 | ||||||
Specialty Plastics
|
292 | 307 | ||||||
Total Sales
|
$ | 1,821 | $ | 1,758 |
First Three Months
|
||||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
Operating Earnings (Loss)
|
||||||||
CASPI
|
$ | 98 | $ | 104 | ||||
Fibers
|
101 | 86 | ||||||
PCI
|
77 | 94 | ||||||
Specialty Plastics
|
30 | 35 | ||||||
Total Operating Earnings by Segment
|
306 | 319 | ||||||
Other (1)(2)
|
||||||||
Growth initiatives
|
(26 | ) | (14 | ) | ||||
Pension and OPEB costs not allocated to operating segments
|
(7 | ) | 9 | |||||
Transaction costs related to the pending acquisition of Solutia
|
(9 | ) | -- | |||||
Total Operating Earnings
|
$ | 264 | $ | 314 |
(1)
|
Research and development, pension and OPEB, and other expenses not identifiable to an operating segment are not included in segment operating results for either of the periods presented and are shown as "other" operating earnings (loss).
|
(2)
|
First quarter 2011 included a $15 million MTM gain due to an interim remeasurement of the OPEB plan obligation, triggered by the exit of employees associated with the sale of the PET business. See Note 4, "Discontinued Operations" for additional information.
|
March 31,
|
December 31,
|
|||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
Assets by Segment (1)
|
||||||||
CASPI
|
$ | 1,398 | $ | 1,373 | ||||
Fibers
|
932 | 921 | ||||||
PCI
|
1,533 | 1,471 | ||||||
Specialty Plastics
|
1,210 | 1,194 | ||||||
Total Assets by Segment
|
5,073 | 4,959 | ||||||
Corporate Assets
|
1,118 | 1,225 | ||||||
Total Assets
|
$ | 6,191 | $ | 6,184 |
(1)
|
The chief operating decision maker holds segment management accountable for accounts receivable, inventory, fixed assets, goodwill, and intangible assets.
|
20.
|
RECENTLY ISSUED ACCOUNTING STANDARDS
|
ITEM
|
Page
|
26
|
|
26
|
|
27
|
|
28
|
|
31
|
|
35
|
|
36
|
|
40
|
|
40
|
|
41
|
|
·
|
Company other charges (income), net, earnings from continuing operations, and diluted earnings per share excluding financing costs related to the pending acquisition of Solutia Inc. ("Solutia"), described below; and
|
·
|
Company gross profit, selling, general and administrative ("SG&A") and research and development ("R&D") expenses, operating earnings, earnings from continuing operations, and diluted earnings per share excluding transaction costs related to the pending acquisition of Solutia and OPEB plan interim MTM gain, also described below.
|
·
|
expanding PCI segment capacity to support its non-phthalate plasticizer business, including retrofitting the acquired Sterling Chemicals, Inc. ("Sterling") idled plasticizer manufacturing unit and increasing capacity of 2-ethyl hexanol ("2-EH") to support expected growth in the plasticizers, coatings, and fuel additive markets;
|
·
|
completing Specialty Plastics segment capacity expansions for cyclohexane dimethanol ("CHDM"), a monomer used in the manufacture of copolyesters, and cellulose triacetate;
|
·
|
completing the formal commercial introduction of acetylated wood, branded as Perennial WoodTM, to select markets;
|
·
|
commercial introduction of the new Eastman CerfisTM technology, with anticipation that the application will be expanded nationwide by the end of 2012; and
|
·
|
entering into a definitive agreement to acquire Solutia, a global leader in performance materials and specialty chemicals, which is expected to:
|
o
|
broaden Eastman's global presence, particularly in Asia Pacific;
|
o
|
establish a combined platform with extensive organic growth opportunities through complementary technologies and business capabilities and an overlap of key end-markets; and
|
o
|
expand Eastman's portfolio of sustainable products.
|
First Quarter
|
Volume Effect
|
Price Effect
|
Product
Mix Effect
|
Exchange
Rate
Effect
|
||||||||||
(Dollars in millions)
|
2012
|
2011
|
Change
|
|||||||||||
Sales
|
$
|
1,821
|
$
|
1,758
|
4 %
|
-- %
|
3 %
|
1 %
|
-- %
|
First Quarter
|
||||||||||||
(Dollars in millions)
|
2012
|
2011
|
Change
|
|||||||||
Gross Profit
|
$ | 431 | $ | 458 | (6 | ) % | ||||||
As a percentage of sales
|
24 | % | 26 | % | ||||||||
Mark-to-market pension and other postretirement benefit adjustments
|
-- | (12 | ) | |||||||||
Gross Profit excluding item
|
$ | 431 | $ | 446 | (3 | ) % | ||||||
As a percentage of sales
|
24 | % | 25 | % |
First Quarter
|
||||||||||||
(Dollars in millions)
|
2012
|
2011
|
Change
|
|||||||||
Selling, General and Administrative Expenses
|
$ | 126 | $ | 108 | 17 | % | ||||||
Research and Development Expenses
|
41 | 36 | 14 | % | ||||||||
$ | 167 | $ | 144 | 16 | % | |||||||
As a percentage of sales
|
9 | % | 8 | % | ||||||||
Transaction costs related to the pending acquisition of Solutia
|
(9 | ) | -- | |||||||||
Mark-to-market pension and other postretirement benefit adjustments
|
-- | 3 | ||||||||||
Selling, General, and Administrative Expenses and Research and Development Expenses excluding items
|
$ | 158 | $ | 147 | 7 | % | ||||||
As a percentage of sales
|
9 | % | 8 | % |
First Quarter
|
||||||||||||
(Dollars in millions)
|
2012
|
2011
|
Change
|
|||||||||
Operating earnings
|
$ | 264 | $ | 314 | (16 | ) % | ||||||
Transaction costs related to the pending acquisition of Solutia
|
9 | -- | ||||||||||
Mark-to-market pension and other postretirement benefit adjustments
|
-- | (15 | ) | |||||||||
Operating earnings excluding items
|
$ | 273 | $ | 299 | (9 | ) % |
First Quarter
|
||||||||||||
(Dollars in millions)
|
2012
|
2011
|
Change
|
|||||||||
Gross interest costs
|
$ | 23 | $ | 23 | ||||||||
Less: Capitalized interest
|
2 | 2 | ||||||||||
Interest expense
|
21 | 21 | -- | % | ||||||||
Interest income
|
2 | 2 | ||||||||||
Net interest expense
|
$ | 19 | $ | 19 | -- | % | ||||||
First Quarter
|
||||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
Foreign exchange transaction gains
|
$ | (1 | ) | $ | (1 | ) | ||
Solutia financing costs
|
5 | -- | ||||||
Investment (gains) losses, net
|
(3 | ) | (6 | ) | ||||
Other, net
|
-- | 1 | ||||||
Other charges (income), net
|
$ | 1 | $ | (6 | ) | |||
Solutia financing costs
|
(5 | ) | -- | |||||
Other charges (income), net excluding Solutia financing costs
|
$ | (4 | ) | $ | (6 | ) |
First Quarter
|
||||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
Provision for income taxes
|
$ | 85 | $ | 100 | ||||
Effective tax rate
|
35 | % | 33 | % |
First Quarter
|
||||||||||||||||
2012
|
2011
|
|||||||||||||||
(Dollars in millions, except diluted EPS)
|
$ | EPS | $ | EPS | ||||||||||||
Earnings from continuing operations
|
$ | 159 | $ | 1.13 | $ | 201 | $ | 1.39 | ||||||||
Solutia transaction and financing costs, net of tax
|
13 | 0.09 | -- | -- | ||||||||||||
Mark-to-market pension and other postretirement benefit adjustments, net of tax
|
-- | -- | (10 | ) | (0.07 | ) | ||||||||||
Earnings from continuing operations excluding items, net of tax
|
$ | 172 | $ | 1.22 | $ | 191 | $ | 1.32 |
First Quarter
|
||||||||||||||||
2012
|
2011
|
|||||||||||||||
(Dollars in millions, except diluted EPS)
|
$ | EPS | $ | EPS | ||||||||||||
Earnings from continuing operations
|
$ | 159 | $ | 1.13 | $ | 201 | $ | 1.39 | ||||||||
Earnings from discontinued operations, net of tax
|
-- | -- | 9 | 0.07 | ||||||||||||
Gain (loss) from disposal of discontinued operations, net of tax
|
(1 | ) | (0.01 | ) | 30 | 0.20 | ||||||||||
Net earnings
|
$ | 158 | $ | 1.12 | $ | 240 | $ | 1.66 |
CASPI Segment
|
||||||||
First Quarter
|
||||||||
Change
|
||||||||
(Dollars in millions)
|
2012
|
2011
|
$
|
%
|
||||
Sales
|
$
|
470
|
$
|
467
|
$
|
3
|
1 %
|
|
Volume effect
|
(3)
|
(1) %
|
||||||
Price effect
|
13
|
3 %
|
||||||
Product mix effect
|
(6)
|
(1) %
|
||||||
Exchange rate effect
|
(1)
|
-- %
|
||||||
Operating earnings
|
98
|
104
|
(6)
|
(6) %
|
||||
Fibers Segment
|
||||||||
First Quarter
|
||||||||
Change
|
||||||||
(Dollars in millions)
|
2012
|
2011
|
$
|
%
|
||||
Sales
|
$
|
323
|
$
|
290
|
$
|
33
|
11 %
|
|
Volume effect
|
5
|
1 %
|
||||||
Price effect
|
17
|
6 %
|
||||||
Product mix effect
|
11
|
4 %
|
||||||
Exchange rate effect
|
--
|
-- %
|
||||||
Operating earnings
|
101
|
86
|
15
|
18 %
|
||||
PCI Segment
|
||||||||
First Quarter
|
||||||||
Change
|
||||||||
(Dollars in millions)
|
2012
|
2011
|
$
|
%
|
||||
Sales
|
$
|
736
|
$
|
694
|
$
|
42
|
6 %
|
|
Volume effect
|
29
|
4 %
|
||||||
Price effect
|
3
|
1 %
|
||||||
Product mix effect
|
10
|
1 %
|
||||||
Exchange rate effect
|
--
|
-- %
|
||||||
Operating earnings
|
77
|
94
|
(17)
|
(18) %
|
||||
Specialty Plastics Segment
|
||||||||
First Quarter
|
||||||||
Change
|
||||||||
(Dollars in millions)
|
2012
|
2011
|
$
|
%
|
||||
Sales
|
$
|
292
|
$
|
307
|
$
|
(15)
|
(5) %
|
|
Volume effect
|
(27)
|
(9) %
|
||||||
Price effect
|
15
|
5 %
|
||||||
Product mix effect
|
(3)
|
(1) %
|
||||||
Exchange rate effect
|
--
|
-- %
|
||||||
Operating earnings
|
30
|
35
|
(5)
|
(14) %
|
||||
First Quarter
|
||||||||||||||||||||||||||||
(Dollars in millions)
|
2012
|
2011
|
Change
|
Volume Effect
|
Price Effect
|
Product
Mix Effect
|
Exchange
Rate
Effect
|
|||||||||||||||||||||
United States and Canada
|
$ | 1,002 | $ | 918 | 9 | % | 4 | % | 3 | % | 2 | % | -- | % | ||||||||||||||
Asia Pacific
|
388 | 397 | (2 | ) % | (4 | ) % | 2 | % | -- | % | -- | % | ||||||||||||||||
Europe, Middle East, and Africa
|
346 | 355 | (2 | ) % | (5 | ) % | 4 | % | -- | % | (1 | ) % | ||||||||||||||||
Latin America
|
85 | 88 | (3 | ) % | (1 | ) % | 2 | % | (4 | ) % | -- | % | ||||||||||||||||
$ | 1,821 | $ | 1,758 | 4 | % | -- | % | 3 | % | 1 | % | -- | % |
First Three Months
|
||||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
Net cash provided by (used in)
|
||||||||
Operating activities
|
$ | 19 | $ | (146 | ) | |||
Investing activities
|
(10 | ) | 307 | |||||
Financing activities
|
(17 | ) | (37 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents
|
-- | -- | ||||||
Net change in cash and cash equivalents
|
(8 | ) | 124 | |||||
|
||||||||
Cash and cash equivalents at beginning of period
|
577 | 516 | ||||||
Cash and cash equivalents at end of period
|
$ | 569 | $ | 640 |
March 31,
|
December 31,
|
|||||||
(Dollars in millions)
|
2012
|
2011
|
||||||
Cash and cash equivalents
|
$ | 569 | $ | 577 | ||||
Short-term time deposits
|
80 | 200 | ||||||
Total cash and cash equivalents and short-term time deposits
|
$ | 649 | $ | 777 |
(Dollars in millions)
|
Payments Due for
|
|||||||||||||||||||||||||||
Period
|
Notes and Debentures
|
Credit Facility Borrowings and Other
|
Interest Payable
|
Purchase Obligations
|
Operating Leases
|
Other Liabilities (a)
|
Total
(b)
|
|||||||||||||||||||||
2012
|
$ | 147 | $ | 4 | $ | 64 | $ | 207 | $ | 24 | $ | 158 | $ | 604 | ||||||||||||||
2013
|
-- | -- | 81 | 303 | 27 | 51 | 462 | |||||||||||||||||||||
2014
|
-- | -- | 81 | 73 | 17 | 52 | 223 | |||||||||||||||||||||
2015
|
250 | -- | 82 | 148 | 15 | 56 | 551 | |||||||||||||||||||||
2016
|
-- | 74 | 140 | 14 | 67 | 295 | ||||||||||||||||||||||
2017 and beyond
|
1,194 | -- | 454 | 615 | 37 | 1,080 | 3,380 | |||||||||||||||||||||
Total
|
$ | 1,591 | $ | 4 | $ | 836 | $ | 1,486 | $ | 134 | $ | 1,464 | $ | 5,515 |
(a)
|
Amounts represent the current estimated cash payments to be made by the Company primarily for pension and other post-employment benefits and taxes payable in the periods indicated. The amount and timing of such payments is dependent upon interest rates, health care cost trends, actual returns on plan assets, retirement and attrition rates of employees, continuation or modification of the benefit plans, and other factors. Such factors can significantly impact the amount and timing of any future contributions by the Company.
|
(b)
|
Not included in the above table is the expected payment of approximately $2.7 billion in cash in order to complete the pending Solutia acquisition or any obligations to be assumed upon completion of the pending acquisition of Solutia.
|
·
|
that the parties may not be able to satisfy the conditions to the completion of the merger and that the merger may not be completed;
|
·
|
that the Company may not complete the pending acquisition of Solutia on terms contained in the merger agreement, which could impact the purchase price to be paid, assets to be acquired, covenants relating to Eastman's or Solutia's operations, or timing thereof;
|
·
|
that the Company may continue to incur significant additional costs and expend significant additional time and effort prior to the closing and if the transaction is delayed or not consummated, the Company may not be able to realize any benefit therefrom;
|
·
|
that the financing costs to complete the acquisition may be significantly higher than expected; and
|
·
|
that Solutia can require Eastman to complete the acquisition in certain situations that could result in the Company incurring significant additional costs.
|
·
|
that the financial performance of the acquired businesses may be significantly worse than expected;
|
·
|
that the Company will have significant additional indebtedness as a result of the acquisition;
|
·
|
that the Company may not be able to achieve the cost, revenue, or tax synergies expected from the pending acquisition of Solutia, or that there may be delays in achieving any such synergies; and
|
·
|
that the Company may be required to expend significant additional resources in order to integrate Solutia's businesses into Eastman's.
|
Eastman Chemical Company
|
|||
Date: May 10, 2012
|
By:
|
/s/ Curtis E. Espeland | |
Curtis E. Espeland
|
|||
Senior Vice President and Chief Financial Officer
|
EXHIBIT INDEX
|
Sequential
|
|||
Exhibit
|
Page
|
|||
Number
|
Description
|
Number
|
||
2.01 | Agreement and Plan of Merger, dated January 26, 2012, by and among Eastman Chemical Company, Solutia Inc. and Eagle Merger Sub Corporation (incorporated herein by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K dated January 26, 2012) | |||
Amended and Restated Certificate of Incorporation of Eastman Chemical Company
|
50 | |||
Amended and Restated Bylaws of Eastman Chemical Company
|
57 | |||
4.01
|
Form of Eastman Chemical Company common stock certificate as amended February 1, 2001 (incorporated herein by reference to Exhibit 4.01 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2001)
|
|||
4.02
|
Indenture, dated as of January 10, 1994, between Eastman Chemical Company and The Bank of New York, as Trustee (the "Indenture") (incorporated herein by reference to Exhibit 4(a) to the Company's Current Report on Form 8-K dated January 10, 1994)
|
|||
4.03
|
Form of 7 1/4% Debentures due January 15, 2024 (incorporated herein by reference to Exhibit 4(d) to the Company's Current Report on Form 8-K dated January 10, 1994)
|
|||
4.04
|
Officers' Certificate pursuant to Sections 201 and 301 of the Indenture (incorporated herein by reference to Exhibit 4(a) to the Company's Current Report on Form 8-K dated June 8, 1994)
|
|||
4.05
|
Form of 7 5/8% Debentures due June 15, 2024 (incorporated herein by reference to Exhibit 4(b) to the Company's Current Report on Form 8-K dated June 8, 1994)
|
|||
4.06
|
Form of 7.60% Debentures due February 1, 2027 (incorporated herein by reference to Exhibit 4.08 to the Company's Annual Report on Form 10-K for the year ended December 31, 1996)
|
|||
4.07
|
Officer's Certificate pursuant to Sections 201 and 301 of the Indenture related to 7.60% Debentures due February 1, 2027 (incorporated herein by reference to Exhibit 4.09 to the Company's Annual Report on Form 10-K for the year ended December 31, 2006)
|
|||
4.08
|
Form of 5.500% Notes due 2019 (incorporated herein by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K dated November 2, 2009)
|
|||
4.09 | Form of 6.30% Notes due 2018 (incorporated herein by reference to Exhibit 4.14 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2003) | |||
4.10 | Form of 3% Note due 2015 (incorporated herein by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K dated December 10, 2010) | |||
4.11 | Form of 4.5% Note due 2021 (incorporated herein by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K dated December 10, 2010) | |||
10.01 | April 30, 2012 Letter Amendment to $250,000,000 Accounts Receivable Securitization agreement dated July 9, 2008 (amended February 18, 2009, July 8, 2009, July 7, 2010, January 31, 2011, and July 6, 2011), between the Company and The Bank of Tokyo-Mitsubishi UFJ, Ltd., as agent. (incorporated herein by reference to Exhibit 4.09 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2009, Exhibit 4.10 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, Exhibit 4.10 to the Company's Annual Report on Form 10-K for the year ended December 31, 2010, and Exhibit 4.10 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2011) | 69 | ||
EXHIBIT INDEX | Sequential | |||
Exhibit | Page | |||
Number | Description | Number | ||
10.02 | Five-Year Credit Agreement, dated as of December 7, 2011 (the "New Credit Agreement"), among Eastman Chemical Company, the initial lenders named therein, and Citibank N.A., as administrative agent, Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as joint lead arrangers (incorporated herein by reference to Exhibit 10.01 to the Company's Current Report on Form 8-K dated December 6, 2011) | |||
10.03 |
Five-Year Senior Term Loan Credit Agreement, dated as of February 29, 2012, by and among Eastman Chemical Company, the initial lenders named therein, Citibank, N.A., as administrative agent, Citigroup Global Markets Inc. and Barclays Capital, as joint lead arrangers, and Barclays Capital, as syndication agent (incorporated herein by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated March 6, 2012)
|
|||
10.04 |
Senior Bridge Term Loan Credit Agreement, dated as of February 29, 2012, by and among Eastman Chemical Company, the initial lenders named therein, Citibank, N.A., as administrative agent, Citigroup Global Markets Inc. and Barclays Capital, as joint lead arrangers, Barclays Capital, as syndication agent, and Bank of America, N.A., JPMorgan Chase Bank, N.A., RBS Securities Inc. and Wells Fargo Bank, National Association, as co-arrangers (incorporated herein by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K dated March 6, 2012)
|
|||
10.05 | 2012 Omnibus Stock Compensation Plan (incorporated herein by reference to Appendix A of the Company's 2012 Annual Meeting Proxy Statement dated March 21, 2012) | |||
10.06 | 2012 Director Stock Compensation Subplan and Form of Restricted Stock Award Notice | 73 | ||
10.07 | Amended and Restated Eastman Executive Deferred Compensation Plan | 79 | ||
12.01 | Statement re: Computation of Ratios of Earnings to Fixed Charges | 95 | ||
18.01 | Preferability Letter of Independent Registered Public Firm | 96 | ||
31.01 |
Rule 13a – 14(a) Certification by James P. Rogers, Chief Executive Officer, for the quarter ended March 31, 2012
|
97 | ||
31.02 | Rule 13a – 14(a) Certification by Curtis E. Espeland, Senior Vice President and Chief Financial Officer, for the quarter ended March 31, 2012 | 98 | ||
32.01 | Section 1350 Certification by James P. Rogers, Chief Executive Officer, for the quarter ended March 31, 2012 | 99 | ||
32.02 | Section 1350 Certification by Curtis E. Espeland, Senior Vice President and Chief Financial Officer, for the quarter ended March 31, 2012 | 100 | ||
101.INS | XBRL Instance Document | |||
101.SCH | XBRL Taxonomy Extension Schema | |||
101.CAL | XBRL Taxonomy Calculation Linkbase | |||
101.LAB | XBRL Taxonomy Label Linkbase | |||
101.PRE | Presentation Linkbase Document | |||
101.DEF | XBRL Definition Linkbase Document |
|
(a) “Committee” means the Nominating and Corporate Governance Committee of the Board.
|
(b) “Effective Date” of the Plan has the meaning set forth in Section 7.4 hereof. |
|
(c) “Eligible Participant” means any person who is a Non-Employee Director on the Effective Date or becomes a Non-Employee Director while this Plan is in effect; except that during any period a director is prohibited from participating in the Plan by his or her employer or otherwise waives participation in the Plan, such director shall not be an Eligible Participant.
|
|
(d) “Omnibus Plan” means the Eastman Chemical Company 2012 Omnibus Stock Compensation Plan, or any subsequent equity compensation plan approved by the Board and designated as the Omnibus Plan for purposes of this Plan.
|
|
(e) “Plan” means this Eastman Chemical Company 2012 Director Stock Compensation Subplan, as amended from time to time. The Plan is a subplan of the Omnibus Plan.
|
|
(f) “Plan Year(s)” means the approximate twelve-month periods between annual meetings of the stockholders of the Company, which, for purposes of the Plan, are the periods for which equity Awards are earned.
|
|
(a) Vesting of Awards. Upon a Change in Control: (i) the terms of this Section 5.4 shall immediately become operative, without further action or consent by any person or entity; (ii) all conditions, restrictions, and limitations in effect on Restricted Stock Awards pursuant to this Plan shall immediately lapse as of the date of such event; (iii) no other terms, conditions, restrictions or limitations shall be imposed upon any such Awards on or after such date, and in no circumstance shall such Awards be forfeited on or after such date; and (iv) all such Awards shall automatically become one hundred percent (100%) vested immediately.
|
|
(b) Valuation and Payment of Awards. Upon a Change in Control, each Non-Employee Director, whether or not continuing in service as a director of the Company in any capacity, shall be paid, in a single lump-sum cash payment, as soon as practicable but in no event later than seventy-five (75) days after the effective date of the Change in Control, the value of all of his or her outstanding Restricted Stock Awards. For purposes of calculating the cash-out value of Awards for purposes of this Section 5.4, the Fair Market Value of Shares as of the date of the Change in Control shall be used as the Fair Market Value of the Shares.
|
First Quarter
|
||||
(Dollars in millions)
|
2012
|
2011
|
||
Earnings from continuing operations before income taxes
|
$
|
244
|
$
|
301
|
Add:
|
||||
Interest expense
|
21
|
21
|
||
Appropriate portion of rental expense (3)
|
4
|
3
|
||
Amortization of capitalized interest
|
2
|
2
|
||
Earnings as adjusted
|
$
|
271
|
$
|
327
|
Fixed charges:
|
||||
Interest expense
|
21
|
21
|
||
Appropriate portion of rental expense (3)
|
4
|
3
|
||
Capitalized interest
|
1
|
2
|
||
Total fixed charges
|
$
|
26
|
$
|
26
|
Ratio of earnings to fixed charges
|
10.4x
|
12.6x
|
||
(1)
|
The Company completed the sale of the polyethylene terephthalate ("PET") business, related assets at the Columbia, South Carolina, site, and technology of its Performance Polymers segment on January 31, 2011. The PET business, assets, and technology sold were substantially all of the Performance Polymers segment. Performance Polymers segment operating results are presented as discontinued operations for all periods presented. For additional information, see Note 4, "Discontinued Operations" to the Company's consolidated financial statements in this 2012 Quarterly Report on Form 10-Q.
|
(2)
|
As previously reported on March 7, 2012, Eastman has elected to change its method of accounting for actuarial gains and losses for its pension and other postretirement benefit plans to a more preferable method permitted under accounting principles generally accepted in the United States. The new method has been retrospectively applied to the financial results of all periods presented. For additional information, see Note 2, "Accounting Methodology Change for Pension and Other Postretirement Benefit Plans " to the Company's consolidated financial statements in this 2012 Quarterly Report on Form 10-Q.
|
(3)
|
For all periods presented, the interest component of rental expense is estimated to equal one-third of such expense.
|
1. | I have reviewed this quarterly report on Form 10-Q of Eastman Chemical Company; |
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
|
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
|
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
1. | I have reviewed this quarterly report on Form 10-Q of Eastman Chemical Company; |
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
|
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
|
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
1.
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.
|
1.
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.
|
SEGMENT INFORMATION (Tables)
|
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SEGMENT INFORMATION [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information Disclosure |
|
DERIVATIVES Part 1 (Details)
|
3 Months Ended | |||||
---|---|---|---|---|---|---|
Mar. 31, 2012
USD ($)
MMBbls
MMBTU
|
Mar. 31, 2012
EUR (€)
|
Mar. 31, 2012
JPY (¥)
|
Dec. 31, 2011
USD ($)
MMBTU
MMBbls
|
Dec. 31, 2011
EUR (€)
|
Dec. 31, 2011
JPY (¥)
|
|
Hedging Programs [Abstract] | ||||||
Objectives for Using Derivative Instruments | The Company is exposed to market risk, such as changes in currency exchange rates, raw material and energy costs, and interest rates. The Company uses various derivative financial instruments when appropriate pursuant to the Company's hedging policies to mitigate these market risk factors and their effect on the cash flows of the underlying transactions. Designation is performed on a specific exposure basis to support hedge accounting. The changes in fair value of these hedging instruments are offset in part or in whole by corresponding changes in the cash flows of the underlying exposures being hedged. The Company does not hold or issue derivative financial instruments for trading purposes. | The Company is exposed to market risk, such as changes in currency exchange rates, raw material and energy costs, and interest rates. The Company uses various derivative financial instruments when appropriate pursuant to the Company's hedging policies to mitigate these market risk factors and their effect on the cash flows of the underlying transactions. Designation is performed on a specific exposure basis to support hedge accounting. The changes in fair value of these hedging instruments are offset in part or in whole by corresponding changes in the cash flows of the underlying exposures being hedged. The Company does not hold or issue derivative financial instruments for trading purposes. | The Company is exposed to market risk, such as changes in currency exchange rates, raw material and energy costs, and interest rates. The Company uses various derivative financial instruments when appropriate pursuant to the Company's hedging policies to mitigate these market risk factors and their effect on the cash flows of the underlying transactions. Designation is performed on a specific exposure basis to support hedge accounting. The changes in fair value of these hedging instruments are offset in part or in whole by corresponding changes in the cash flows of the underlying exposures being hedged. The Company does not hold or issue derivative financial instruments for trading purposes. | |||
Fair Value Hedges [Abstract] | ||||||
Notional Amount of Interest Rate Fair Value Hedge Derivatives | $ 0 | $ 0 | ||||
Cash Flow Hedges [Abstract] | ||||||
Notional Amount of Foreign Exchange Forward and Option Contracts (EUR) | 465,000,000 | 347,000,000 | 350,000,000 | 270,000,000 | ||
Notional Amount of Foreign Exchange Option Contracts (in Japanese Yen) | 155,000,000 | 12,500,000,000 | 185,000,000 | 13,700,000,000 | ||
Nonmonetary Notional amount of Derivative Energy Contracts (in million British thermal units - mmbtu) | 0 | 0 | 0 | 1 | 1 | 1 |
Nonmonetary Notional amount of Derivative Raw Material Contracts (in million barrels) | 1 | 1 | 1 | 2 | 2 | 2 |
Notional Amount Interest Rate Swaps For Future Debt Issuance | $ 750,000,000 | $ 200,000,000 |
EARNINGS AND DIVIDENDS PER SHARE (Details) (USD $)
|
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2012
|
Mar. 31, 2011
|
Oct. 03, 2011
|
|
EARNINGS AND DIVIDENDS PER SHARE [Abstract] | |||
Shares used for earnings per share calculation, Basic (in shares) | 137,300,000 | 141,400,000 | |
Shares used for earnings per share calculation, Diluted (in shares) | 140,700,000 | 144,600,000 | |
Stock Split | On August 5, 2011, the Company's Board of Directors declared a two-for-one split of the Company's common stock in the form of a 100 percent stock dividend. Stockholders of record as of September 15, 2011 were issued one additional share of common stock on October 3, 2011 for each share held. Treasury shares were treated as shares outstanding in the stock split. | ||
Stock split, stock issued to stockholders of record per share held | 1 | ||
Underlying options excluded from the computation of diluted earnings per share (in shares) | 0 | 161,800 | |
Shares repurchased (in shares) | 0 | 1,700,000 | |
Cash dividends declared (per share) | $ 0.26 | $ 0.235 |
PROVISION FOR INCOME TAXES (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | |
---|---|---|
Mar. 31, 2012
|
Mar. 31, 2011
|
|
PROVISION FOR INCOME TAXES [Abstract] | ||
Provision for income taxes from continuing operations | $ 85 | $ 100 |
Effective tax rate (in hundredths) | 35.00% | 33.00% |
Expected full year tax rate (in hundredths) | 33.00% |
DERIVATIVES (Tables)
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DERIVATIVES [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Financial Assets and Liabilities Based on Fair Value Level 2 Hierarchy on Recurring Basis and Balance Sheet Location | Fair Value of Derivatives Designated as Hedging Instruments
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instrument Gain Loss in Statement of Financial Performance | Derivatives' Hedging Relationships
|
SHARE-BASED COMPENSATION AWARDS (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | |
---|---|---|
Mar. 31, 2012
|
Mar. 31, 2011
|
|
Share-based awards under employee and non-employee director compensation programs | ||
Share-based compensation expense before tax in selling, general and administrative expenses | $ 9 | $ 7 |
Share-based compensation net of deferred tax expense | $ 5 | $ 4 |
RECENTLY ISSUED ACCOUNTING STANDARDS
|
3 Months Ended |
---|---|
Mar. 31, 2012
|
|
Description Of New Accounting Pronouncements Not Yet Adopted [Abstract] | |
RECENTLY ISSUED ACCOUNTING STANDARDS | In December 2011, the Financial Accounting Standards Board and International Accounting Standards Board jointly issued amended accounting guidance to enhance disclosure requirements for instruments and transactions no longer eligible for offset in the statement of financial position as well as instruments and transactions subject to an agreement similar to a master netting arrangement. This guidance is effective for reporting periods beginning on or after January 1, 2013. The Company has concluded that no such netting has been in effect and that the change will have no impact on the Company's financial position or results of operations. |
DERIVATIVES Part 3 (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2012
|
Mar. 31, 2011
|
Dec. 31, 2011
|
|
Amount After Tax of Gain (Loss) Recognized in Other Comprehensive Income On Derivatives, Effective Portion [Abstract] | |||
Unrealized Gains (Losses) on Derivative Instruments | $ 5 | $ (14) | $ (20) |
Pre-tax Amount of Gain (Loss) reclassified From Accumulated Other Comprehensive Income Into Income (Effective Portion) [Abstract] | |||
Derivative Instruments, Gain (Loss) Reclassified From Accumulated Other Comprehensive Income, Effective Portion, Net Total | 8 | 1 | |
Hedging Summary [Abstract] | |||
Monetized positions and mark to market in accumulated other comprehensive income before tax | (3) | (5) | |
Price Risk Cash Flow Hedge Unrealized Gain (Loss) to be Reclassified During Next 12 Months | 21 | ||
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net | (1) | (4) | |
Commodity Contract [Member] | Cash Flow Hedging [Member]
|
|||
Amount After Tax of Gain (Loss) Recognized in Other Comprehensive Income On Derivatives, Effective Portion [Abstract] | |||
Unrealized Gains (Losses) on Derivative Instruments | (7) | 2 | |
Commodity Contract [Member] | Cash Flow Hedging [Member] | Cost of Sales [Member]
|
|||
Pre-tax Amount of Gain (Loss) reclassified From Accumulated Other Comprehensive Income Into Income (Effective Portion) [Abstract] | |||
Derivative Instruments, Gain (Loss) Reclassified From Accumulated Other Comprehensive Income, Effective Portion, Net Total | 0 | 0 | |
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member]
|
|||
Amount After Tax of Gain (Loss) Recognized in Other Comprehensive Income On Derivatives, Effective Portion [Abstract] | |||
Unrealized Gains (Losses) on Derivative Instruments | (1) | (16) | |
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member] | Sales [Member]
|
|||
Pre-tax Amount of Gain (Loss) reclassified From Accumulated Other Comprehensive Income Into Income (Effective Portion) [Abstract] | |||
Derivative Instruments, Gain (Loss) Reclassified From Accumulated Other Comprehensive Income, Effective Portion, Net Total | 8 | 1 | |
Forward Starting Interest Rate Swap [Member] | Cash Flow Hedging [Member]
|
|||
Amount After Tax of Gain (Loss) Recognized in Other Comprehensive Income On Derivatives, Effective Portion [Abstract] | |||
Unrealized Gains (Losses) on Derivative Instruments | 13 | 0 | |
Forward Starting Interest Rate Swap [Member] | Cash Flow Hedging [Member] | Net Interest Expense
|
|||
Pre-tax Amount of Gain (Loss) reclassified From Accumulated Other Comprehensive Income Into Income (Effective Portion) [Abstract] | |||
Derivative Instruments, Gain (Loss) Reclassified From Accumulated Other Comprehensive Income, Effective Portion, Net Total | $ 0 | $ 0 |
ACQUISITIONS AND INVESTMENTS IN JOINT VENTURES (Details) (Eastman Chemical Company [Member], Sterling and Scandiflex Acquisitions [Member], USD $)
In Millions, unless otherwise specified |
3 Months Ended |
---|---|
Mar. 31, 2012
|
|
Eastman Chemical Company [Member] | Sterling and Scandiflex Acquisitions [Member]
|
|
Business Acquisition [Line Items] | |
Transaction costs | $ 4 |
Purchase price and post-closure payment description | The total purchase price for both acquisitions was $133 million, including a post-closing payment of $10 million to the previous shareholders of Scandiflex. |
Acquisition, post-closure payment | 10 |
Fair value purchase price allocation for business acquired [Abstract] | |
Current assets | 33 |
Properties and equipment | 129 |
Intangible assets | 11 |
Other noncurrent assets | 20 |
Goodwill | 33 |
Current liabilities | (23) |
Long-term liabilities | (70) |
Total purchase price | $ 133 |
ASSETS IMPAIRMENTS AND RESTRUCTURING CHARGES, NET (Tables)
|
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ASSET IMPAIRMENTS AND RESTRUCTURING CHARGES (GAINS), NET [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes to restructuring reserve and related activities | The following table summarizes the changes in other asset impairments and restructuring charges and gains, the non-cash reductions attributable to asset impairments, and the cash reductions in shutdown reserves for severance costs and site closure costs paid for full year 2011 and first three months 2012:
|
COMMITMENTS (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended |
---|---|
Mar. 31, 2012
|
|
Purchase obligations and lease commitments [Abstract] | |
Purchase Obligations | $ 1,500 |
Purchase Obligation Description | over a period of approximately 15 years for materials, supplies and energy incident to the ordinary conduct of business |
Operating Lease Commitments, Cancelable Noncancelable and Month-to-month | 134 |
Percentage of Operating Lease Commitments related to machinery and equipment (in hundredths) | 10.00% |
Percentage of Operating Lease Commitments related to real property (in hundredths) | 50.00% |
Percentage of Operating Lease Commitments related to railcars (in hundredths) | 40.00% |
Guarantees [Abstract] | |
Operating Lease Residual Value Guarantees | 110 |
Operating Lease Residual Value Guarantees Expiring in Three Years and Thereafter | $ 110 |
BORROWINGS (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | |
---|---|---|
Mar. 31, 2012
|
Dec. 31, 2011
|
|
Debt Instrument [Line Items] | ||
Borrowings due within one year | $ (151) | $ (153) |
Long-term borrowings, net of current portion | 1,444 | 1,445 |
Fair Value of Borrowings [Abstract] | ||
Long-term Borrowings, Recorded Amount | 1,444 | 1,445 |
Long-term Borrowings, Fair Value | 1,617 | 1,656 |
Credit Facility [Member]
|
||
Credit Facilities [Abstract] | ||
Credit Facility, Description | In December 2011, the Company entered into a $750 million revolving credit agreement (the "Credit Facility") expiring December 2016. The Credit Facility replaces, and has terms substantially similar to, the $700 million revolving credit agreement entered into in April 2006 (the "Prior Credit Facility") which was terminated concurrently with the entry into the Credit Facility. Borrowings under the Credit Facility are subject to interest at varying spreads above quoted market rates and a commitment fee is paid on the total unused commitment. At March 31, 2012 and December 31, 2011, the Company had no outstanding borrowings under the Credit Facility. | |
Credit Facility, Borrowing Capacity | 750 | 750 |
Credit Facility, Expiration | 2016 | |
Credit Facility Covenant Compliance | contain a number of customary covenants and events of default, including the maintenance of certain financial ratios. The Company was in compliance with all such covenants for all periods presented. | |
Accounts Receivable Facility [Member]
|
||
Credit Facilities [Abstract] | ||
Credit Facility, Description | At March 31, 2012, the Company also had a $200 million line of credit under its accounts receivable securitization agreement ("A/R Facility"). Borrowings under the A/R Facility are subject to interest rates based on a spread over the lender's borrowing costs, and the Company pays a fee to maintain availability of the A/R Facility. At March 31, 2012 and December 31, 2011, the Company had no outstanding borrowings under the A/R Facility. | |
Credit Facility, Borrowing Capacity | 200 | 200 |
Credit Facility Covenant Compliance | contain a number of customary covenants and events of default, including the maintenance of certain financial ratios. The Company was in compliance with all such covenants for all periods presented. | |
Bridge Loan Agreement [Member]
|
||
Credit Facilities [Abstract] | ||
Credit Facility, Description | On February 29, 2012, Eastman entered into a $1.2 billion five-year Term Loan Agreement ("Term Loan Agreement") and a $2.3 billion Bridge Loan Agreement ("Bridge Loan Agreement"). Eastman intends to use financing from the Term Loan Agreement and, in certain circumstances, the Bridge Loan Agreement, to pay, in part, the cash portion of the pending acquisition of Solutia and a portion of the fees and expenses related to the acquisition, which may include the repayment of certain outstanding borrowings of Solutia. | |
Credit Facility, Borrowing Capacity | 2,300 | |
Credit Facility Covenant Compliance | contains certain customary representations, warranties and covenants, including maintenance of certain financial ratios. The Company has been in compliance with all such covenants since February 29, 2012. | |
Term Loan Agreement [Member]
|
||
Credit Facilities [Abstract] | ||
Credit Facility, Description | On February 29, 2012, Eastman entered into a $1.2 billion five-year Term Loan Agreement ("Term Loan Agreement") and a $2.3 billion Bridge Loan Agreement ("Bridge Loan Agreement"). Eastman intends to use financing from the Term Loan Agreement and, in certain circumstances, the Bridge Loan Agreement, to pay, in part, the cash portion of the pending acquisition of Solutia and a portion of the fees and expenses related to the acquisition, which may include the repayment of certain outstanding borrowings of Solutia. | |
Credit Facility, Borrowing Capacity | 1,200 | |
Credit Facility Covenant Compliance | contains certain customary representations, warranties and covenants, including maintenance of certain financial ratios. The Company has been in compliance with all such covenants since February 29, 2012. | |
7% notes due 2012 [Member]
|
||
Debt Instrument [Line Items] | ||
Stated Interest Rate (in hundredths) | 7.00% | |
Maturity Date | 2012 | |
Long-term Debt | 147 | 147 |
3% debentures due 2015 [Member]
|
||
Debt Instrument [Line Items] | ||
Stated Interest Rate (in hundredths) | 3.00% | |
Maturity Date | 2015 | |
Long-term Debt | 250 | 250 |
6.30% notes due 2018 [Member]
|
||
Debt Instrument [Line Items] | ||
Stated Interest Rate (in hundredths) | 6.30% | |
Maturity Date | 2018 | |
Long-term Debt | 175 | 176 |
5.5% notes due 2019 [Member]
|
||
Debt Instrument [Line Items] | ||
Stated Interest Rate (in hundredths) | 5.50% | |
Maturity Date | 2019 | |
Long-term Debt | 250 | 250 |
4.5% debentures due 2021 [Member]
|
||
Debt Instrument [Line Items] | ||
Stated Interest Rate (in hundredths) | 4.50% | |
Maturity Date | 2021 | |
Long-term Debt | 250 | 250 |
7 1/4% debentures due 2024 [Member]
|
||
Debt Instrument [Line Items] | ||
Stated Interest Rate (in hundredths) | 7.25% | |
Maturity Date | 2024 | |
Long-term Debt | 243 | 243 |
7 5/8% debentures due 2024 [Member]
|
||
Debt Instrument [Line Items] | ||
Stated Interest Rate (in hundredths) | 7.625% | |
Maturity Date | 2024 | |
Long-term Debt | 54 | 54 |
7.60% debentures due 2027 [Member]
|
||
Debt Instrument [Line Items] | ||
Stated Interest Rate (in hundredths) | 7.60% | |
Maturity Date | 2027 | |
Long-term Debt | 222 | 222 |
Credit Facility Borrowings [Member]
|
||
Debt Instrument [Line Items] | ||
Long-term Debt | 0 | 0 |
Other debt [Member]
|
||
Debt Instrument [Line Items] | ||
Long-term Debt | $ 4 | $ 6 |
DISCONTINUED OPERATIONS
|
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DISCONTINUED OPERATIONS [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DISCONTINUED OPERATIONS |
On January 31, 2011, the Company completed the sale of the polyethylene terephthalate ("PET") business, related assets at the Columbia, South Carolina site, and technology of its Performance Polymers segment for $615 million and recognized a gain of approximately $30 million, net of tax. The Company contracted with the buyer for transition services to supply certain raw materials and services for a period of less than one year. Transition supply agreement revenues of approximately $220 million, relating to raw materials, were more than offset by costs and reported net in cost of sales. The PET business, assets, and technology sold were substantially all of the Performance Polymers segment and therefore the segment operating results are presented as discontinued operations for all periods presented and are not included in results from continuing operations. Operating results of the discontinued operations which were formerly included in the Performance Polymers segment are summarized below:
|